期刊
HIV MEDICINE
卷 19, 期 6, 页码 411-419出版社
WILEY
DOI: 10.1111/hiv.12609
关键词
AIDS; AIDS-related cancer; HIV; mortality; opportunistic infection
资金
- National Eye Institute, the National Institutes of Health, Bethesda, MD [U10 EY 08052]
- Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD [U10 EY 08057]
- University of Wisconsin, Madison School of Medicine, Madison, WI [U10 EY 08067]
- Johns Hopkins Center for AIDS Research grant from the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, Bethesda, MD, USA [1P30AI094189]
- Scientific and Technological Research Council of Turkey [116C090]
ObjectivesThe aim of the study was to estimate the incidence of, determine risk factors for, and investigate the consequences of opportunistic infections (OIs) and malignancies among patients with the acquired immune deficiency syndrome (AIDS) in the era of modern combination antiretroviral therapy (cART). MethodsThree enrolment periods (1998-2002, 2003-2005 and 2006-2012), corresponding to changes in predominant cART regimens, were compared among 1889 participants enrolled in a prospective cohort study, the Longitudinal Study of Ocular Complications of AIDS (LSOCA). Incidences of AIDS-related OIs and cancers were estimated. Multivariate logistic and Cox regression models were used to determine the effect of demographic and clinical characteristics on OIs and mortality. ResultsBetween participants enrolled in the 1998-2002 and 2006-2012 enrolment periods, the incidence of OIs decreased from 27 per 1000 person-years (PY) to 11 per 1000 PY (P < 0.001), and mortality decreased from 41 per 1000 PY to 18 per 1000 PY (P < 0.0001), corresponding to improvements in cART regimens. ConclusionsImprovements in cART regimens led to a progressive decline in the incidence of OIs and mortality between 1999 and 2013 among patients with AIDS in the era of modern cART.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据